Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
In this single-center, longitudinal observational study, we will comprehensively examine clinical characteristics, proteomic, metabolomic, genomic and imaging data to better understand how different heart failure types may develop and progress over time. We will evaluate distinct sub-groups of heart failure (also known as heart failure phenotypes) and cardiomyopathies including amyloidosis with an ultimate goal of bringing the right medications and therapy to the right patients to optimize benefit and minimized side effects, an effort to improve precision medicine in heart failure.
Sponsor: Massachusetts General Hospital
You may qualify if…
- ✓ 18 years and older
- ✓ History of clinical symptoms consistent with HF and at least one of the following supporting evidence of HF:
- ✓ NT-proBNP \> 125 pg/mL
- ✓ BNP \> 35 pg/mL
- ✓ Capillary wedge pressure ≥ 15 mmHg on right heart catheterization or CI \<2.8 L/min/m2
- ✓ LVEDP ≥ 15 mmHg
- ✓ Radiographic evidence of pulmonary edema
- ✓ Improvement in symptoms with diuretic initiation of increase
You may not qualify if…
- ✕ \- End stage renal disease on dialysis
Where it's recruiting
Boston
Source: ClinicalTrials.gov · NCT03480633 · last updated 2025-12-09